Could Teriparatide Replace Percutaneous Vertebral Augmentation for Patients with Osteoporotic Vertebral Compression Fracture to Some Extent? [Letter]
Jiaming Zhou, Yuan Xue Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Yuan XueDepartment of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaTel...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/10e41125d3174454ad58b9ce5bff8471 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Jiaming Zhou, Yuan Xue Department of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaCorrespondence: Yuan XueDepartment of Orthopaedic Surgery, Tianjin Medical University General Hospital, Tianjin, People’s Republic of ChinaTel +86 22 60814688Fax +86 22 27219052Email xueyuanzyy@163.com
We read with great interest the article by Kong et al.1 In their study, the authors found that for patients with osteoporotic vertebral compression fracture (OVCF), treatment with percutaneous kyphoplasty (PKP) and teriparatide showed a lower risk of new vertebral compression fracture (NVCF) and better clinical outcomes than with PKP and basic treatment (calcium and vitamin D). We wish to express our opinion on this topic.
View the original paper by Kong and colleagues
|
|---|